When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EVH - Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible
Evolent Health Inc Class A
2024-03-09 04:50:41 ET
Summary
Health Catalyst reported strong Q4 results, meeting guidance and showing growth in technology and professional services revenue.
The drop in HCAT's share price presents a buying opportunity, as the company's growth initiatives, such as its TEMS offering and next-gen data platform, are expected to drive growth and margin expansion.
HCAT's long-term guidance of exceeding $100 million in EBITDA by FY28 is achievable, and its valuation should improve as it demonstrates execution and margin expansion.